Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Ectodermal Dysplasia v0.48 NFKB2 Bryony Thompson Marked gene: NFKB2 as ready
Ectodermal Dysplasia v0.48 NFKB2 Bryony Thompson Gene: nfkb2 has been classified as Green List (High Evidence).
Ectodermal Dysplasia v0.48 NFKB2 Bryony Thompson Mode of pathogenicity for gene: NFKB2 was changed from None to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Ectodermal Dysplasia v0.47 NFKB2 Bryony Thompson edited their review of gene: NFKB2: Changed mode of pathogenicity: Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Ectodermal Dysplasia v0.47 NFKB2 Bryony Thompson Classified gene: NFKB2 as Green List (high evidence)
Ectodermal Dysplasia v0.47 NFKB2 Bryony Thompson Gene: nfkb2 has been classified as Green List (High Evidence).
Ectodermal Dysplasia v0.46 NFKB2 Bryony Thompson gene: NFKB2 was added
gene: NFKB2 was added to Ectodermal Dysplasia. Sources: NHS GMS
Mode of inheritance for gene: NFKB2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: NFKB2 were set to 31417880; 28778864; 27749582
Phenotypes for gene: NFKB2 were set to Immunodeficiency, common variable, 10 MIM#615577
Review for gene: NFKB2 was set to GREEN
Added comment: Heterozygous C-terminal variants (both stopgain and missense) with gain-of-function effects cause early onset common variable immunodeficiency (CVID) with ectodermal dysplasia, while loss of function cause CVID without ectodermal manifestations. >3 cases reported with ectodermal dysplasia as a feature of the condition.
Sources: NHS GMS